Comments

Ocuphire Pharma

OCUPNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$2.08
0.020.97%
Last update: 5:31 PM
15 minutes delayed
Ocuphire Pharma (OCUP) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$26.00
Lowest Price Target1
$17.00
Consensus Price Target1
$20.20

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Ocuphire Pharma (NASDAQ:OCUP) Stock, Analyst Ratings, Price Targets, Forecasts

Ocuphire Pharma Inc has a consensus price target of $20.2 based on the ratings of 5 analysts. The high is $26 issued by HC Wainwright & Co. on November 24, 2021. The low is $17 issued by Cantor Fitzgerald on August 14, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Canaccord Genuity, and Alliance Global Partners on May 13, 2024, May 13, 2024, and March 20, 2024, respectively. With an average price target of $19.33 between HC Wainwright & Co., Canaccord Genuity, and Alliance Global Partners, there's an implied 856.95% upside for Ocuphire Pharma Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Canaccord Genuity
Alliance Global Partners
Cantor Fitzgerald
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Ocuphire Pharma

Buy NowGet Alert
05/13/2024Buy Now889.95%HC Wainwright & Co.
Matthew Caufield
 → $20ReiteratesBuy → BuyGet Alert
05/13/2024Buy Now790.96%Canaccord Genuity
John Newman
$22 → $18MaintainsBuyGet Alert
03/20/2024Buy Now889.95%Alliance Global Partners
James Molloy
$24 → $20MaintainsBuyGet Alert
03/11/2024Buy Now889.95%HC Wainwright & Co.
Matthew Caufield
 → $20ReiteratesBuy → BuyGet Alert
11/14/2023Buy Now889.95%HC Wainwright & Co.
Matthew Caufield
 → $20ReiteratesBuy → BuyGet Alert
08/14/2023Buy Now741.46%Cantor Fitzgerald
Kristen Kluska
 → $17ReiteratesOverweight → OverweightGet Alert
08/14/2023Buy Now889.95%HC Wainwright & Co.
Matthew Caufield
 → $20ReiteratesBuy → BuyGet Alert
05/16/2023Buy Now889.95%HC Wainwright & Co.
Matthew Caufield
 → $20ReiteratesBuy → BuyGet Alert
03/31/2023Buy Now889.95%HC Wainwright & Co.
Matthew Caufield
 → $20Reiterates → BuyGet Alert
02/17/2023Buy Now889.95%HC Wainwright & Co.
Matthew Caufield
 → $20Reiterates → BuyGet Alert
01/26/2023Buy Now889.95%HC Wainwright & Co.
Matthew Caufield
$26 → $20MaintainsBuyGet Alert
11/24/2021Buy Now1186.94%HC Wainwright & Co.
Andrew Fein
—Initiates → BuyGet Alert

FAQ

Q

What is the target price for Ocuphire Pharma (OCUP) stock?

A

The latest price target for Ocuphire Pharma (NASDAQ:OCUP) was reported by HC Wainwright & Co. on May 13, 2024. The analyst firm set a price target for $20.00 expecting OCUP to rise to within 12 months (a possible 861.54% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Ocuphire Pharma (OCUP)?

A

The latest analyst rating for Ocuphire Pharma (NASDAQ:OCUP) was provided by HC Wainwright & Co., and Ocuphire Pharma reiterated their buy rating.

Q

When was the last upgrade for Ocuphire Pharma (OCUP)?

A

There is no last upgrade for Ocuphire Pharma

Q

When was the last downgrade for Ocuphire Pharma (OCUP)?

A

There is no last downgrade for Ocuphire Pharma.

Q

When is the next analyst rating going to be posted or updated for Ocuphire Pharma (OCUP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocuphire Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocuphire Pharma was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.

Q

Is the Analyst Rating Ocuphire Pharma (OCUP) correct?

A

While ratings are subjective and will change, the latest Ocuphire Pharma (OCUP) rating was a reiterated with a price target of $20.00 to $20.00. The current price Ocuphire Pharma (OCUP) is trading at is $2.08, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch